Proteomics

Dataset Information

0

Extrinsic inflammatory, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis


ABSTRACT: Multiple sclerosis (MS) is the most frequent demyelinating disease and despite significant advances in the immunotherapy, disease progression still cannot be prevented. Promotion of remyelination, an endogenous repair process, represents a promising new treatment approach. However, spontaneous remyelination frequently fails in MS lesions due to an impaired differentiation of progenitor cells into mature, myelinating oligodendrocytes. Intrinsic oligodendroglial and extrinsic inflammatory factors may contribute to this differentiation block. Therefore, we compared induced pluripotent stem cell (iPSC)-derived oligodendrocytes (hiOL) from MS patients and healthy controls as well as their response to extrinsic factors. While functional capabilities or proteome compostion of both cell types were virtually indistinguishable, we discovered that Interferon-gamma (IFNγ) producing immune cells significantly impaired oligodendroglial differentiation and observed no differences in the functional capabilities or the proteome. In summary, these data indicate that the oligodendroglial differentiation block is not due to intrinsic oligodendroglial factors, but rather caused by the inflammatory environment present in MS lesions. These findings may contribute to the development of remyelination promoting strategies in MS.

INSTRUMENT(S): timsTOF Pro

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Oligodendrocyte

DISEASE(S): Multiple Sclerosis

SUBMITTER: Hannes Drexler  

LAB HEAD: Hannes C. A. Drexler

PROVIDER: PXD016043 | Pride | 2020-09-04

REPOSITORIES: Pride

altmetric image

Publications


Multiple sclerosis (MS) is the most frequent demyelinating disease in young adults and despite significant advances in immunotherapy, disease progression still cannot be prevented. Promotion of remyelination, an endogenous repair mechanism resulting in the formation of new myelin sheaths around demyelinated axons, represents a promising new treatment approach. However, remyelination frequently fails in MS lesions, which can in part be attributed to impaired differentiation of oligodendroglial pr  ...[more]

Similar Datasets

2014-11-06 | E-GEOD-48872 | biostudies-arrayexpress
2021-08-24 | GSE166675 | GEO
2021-08-16 | GSE181933 | GEO
2014-11-06 | GSE48872 | GEO
2010-10-22 | E-GEOD-24821 | biostudies-arrayexpress
2019-07-30 | GSE125325 | GEO
2016-02-17 | GSE44562 | GEO
2022-05-20 | PXD030994 | Pride
2023-08-23 | GSE241451 | GEO
2016-02-17 | E-GEOD-44562 | biostudies-arrayexpress